# Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)

> **NCT00772941** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 3939 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Varenicline

## Key facts

- **NCT ID:** NCT00772941
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 3939 (ACTUAL)
- **Last updated:** 2014-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00772941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00772941, "Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00772941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*